• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    3.29 Down 0.30(8.36%) Feb 5, 4:00PM EST
    |After Hours : 3.29 0.00 (0.00%) Feb 5, 4:49PM EST
    Prev Close:3.59
    Open:3.56
    Bid:N/A
    Ask:37.00 x 100
    1y Target Est:13.33
    Beta:3.66884
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:3.25 - 3.56
    52wk Range:2.65 - 20.63
    Volume:750,432
    Avg Vol (3m):589,082
    Market Cap:115.17M
    P/E (ttm):N/A
    EPS (ttm):-2.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PETX

    Comparison

    Symbol% ChgMkt Cap
    PETXDown 8.36%115.17M
    ZTSDown 1.52%20.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):145.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.08
    Quarterly EPS Est (Dec-15) :-0.41
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback